Dextroamphetamine-Cocaine Behavioral Intervention - 5

Phase 2

Completed

• Conditions: Cocaine-Related Disorders
• Interventions: Drug: placebo; Drug: Dextroamphetamine; Drug: D-amphetamine

• Registration Number: NCT00000308
• Lead Sponsor: National Institute on Drug Abuse (NIDA)

Brief Summary

The purpose of this study is to examine dextroamphetamine-cocaine behavioral intervention in cocaine dependent patients.

Detailed Description

Not available

Study Timeline

• Study Start: 1995-09
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Primary Completion: 2000-09
• Study Completion: 2000-09
• Status Verified: 2016-10
• Last Update Submitted: 2017-01-11
• Last Update Posted: 2017-01-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
3	placebo	placebo
1	Dextroamphetamine	15 mg of d-amphetamine for first 8 weeks of study and 30 mg for the second 8 weeks
2	D-amphetamine	30 mg of d-amphetamine for first 8 weeks of study and 60 mg for the second 8 weeks

Primary Outcome Measures

Name	Time	Method
Verifiable cocaine abstinence	16 weeks of study

Trial Locations

Locations (1)

University of Texas Health Science Center; 🇺🇸 Houston, Texas, United States